Economic impact of the use of rifaximin 550 mg twice daily for the treatment of overt hepatic encephalopathy in Italy

by Roggeri DP, Roggeri A
Published 2017-09-01

Inhalation errors due to device switch in patients with chronic obstructive pulmonary disease and asthma: critical health and economic issues

by Roggeri A, Micheletto C, Roggeri DP
Published 2016-03-01

Outcomes and costs of treating chronic obstructive pulmonary disease with inhaled fixed combinations: the Italian perspective of the PATHOS study

by Roggeri A, Micheletto C, Roggeri DP
Published 2014-06-01

Impact of hospitalizations for bronchiolitis in preterm infants on long-term health care costs in Italy: a retrospective case-control study

by Roggeri DP, Roggeri A, Rossi E, Cataudella S, Martini N
Published 2016-08-01

Organization, Clinical and Management Indicators on the First Year of Activity of an Outpatient Clinic Dedicated to the Diagnosis and Treatment of Severe Asthma in Italy

by Tognella S, Micheletto C, Roggeri A, Polese G, Artioli D, Senna G, Caminati M, Roggeri DP
Published 2021-08-01

Overt hepatic encephalopathy in Italy: clinical outcomes and healthcare costs

by Roggeri DP, Roggeri A, Rossi E, Cinconze E, Gasbarrini A, Monici Preti P, De Rosa M
Published 2015-07-01

Evaluating targets and costs of treatment for secondary hyperparathyroidism in incident dialysis patients: the FARO-2 study

by Roggeri DP, Cozzolino M, Mazzaferro S, Brancaccio D, Paoletti E, Roggeri A, Costanzo AM, di Luzio Paparatti U, Festa V, Messa P
Published 2014-12-01